As promised, we’re letting you know that you can now watch the second set of videos in our no-cost Afib Master Class with Dr. Eric Prystowsky. set of videos, Dr. Prystowsky, a world-renowned electrophysiologist who has long been an advocate for afib patients, answers the questions he hears most frequently from patients about rhythm control. …
Read More
We are excited to announce the availability of a brand-new, no-cost Afib Master Class with afib expert Dr. Eric Prystowsky. Dr. Prystowsky will be a faculty member once again at our upcoming annual Get in Rhythm. Stay in Rhythm.® Atrial Fibrillation Patient Conference. The master class comprises 33 short videos, in which Dr. Prystowsky provides …
Read More
StopAfib interviews Dr. James Reiffel Find a transcript and more on Dr. Reiffel at: www.stopafib.org In this video interview at Heart Rhythm 2012, Dr. James Reiffel updates us on new directions in drug treatments for atrial fibrillation. He talks about the combination of ranolazine (Ranexa) and dronedarone (Multaq), both used …
Read More
At Heart Rhythm 2012, Dr. James Reiffel gave us an update on new medications for treating atrial fibrillation, including the combination of low doses of ranolazine (Ranexa) and dronedarone (Multaq). He also talked about rate control vs. rhythm control for afib, and how the decision can vary by age and level of symptoms. Watch the …
Read More
StopAfib.org interviews Dr. Eric Prystowsky of St. Vincent's Hospital in Indianapolis, Indiana Find more on Dr. Prystowsky: www.stopafib.org Find more on rate control for the treatment of afib at: www.stopafib.org In this video, Dr. Prystowsky discussed the proper application of rate control as a method of controlling atrial fibrillation, as …
Read More
In this video interview recorded at Heart Rhythm 2012, Dr. Eric Prystowsky tackled the controversial topic of rate control vs. rhythm control for treating atrial fibrillation, and knowing whether you are symptomatic or asymptomatic. He also discussed the issues related to leaving afib patients on rate control long term, such as the buildup of fibrosis …
Read More
The wildly beating heart, fatigue and other debilitating symptoms are well known to the many millions of people impacted by atrial fibrillation. Some of those who have afib may have no outward symptoms, but are still at risk of serious and long-term damage to the heart. Symptoms or not, rate control is the common treatment …
Read More
RECORD AF registry findings were presented at the American Heart Association Scientific Sessions. This registry looked at how newly-diagnosed afib patients were being managed in the real world. These results differed from previously-reported research, such as the AFFIRM (Atrial Fibrillation Follow-up Investigation of Rhythm Management) trial. In the real world, more cardiologists chose rhythm drugs …
Read More